TRV GP VI, LLC
Reporting owner on Forms 3, 4 and 5, CIK 1990716.
- Also a 13F filer: TRV GP VI, LLC
- In the filer group Third Rock Ventures VI, L.P.
TRV GP VI, LLC reported on 1 issuer in 9 filings, the latest a 13F-HR filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RAPP · Rapport Therapeutics, Inc.CIK 2012593 | director, 10% owner | 1 | 2026-11-03 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RAPP · Rapport Therapeutics, Inc.Common Stock | 2026-10-30 | A granted | +238,095 | $21 | 6,518,620 | Form 4 |
| RAPP · Rapport Therapeutics, Inc.Common Stock | 2026-10-30 | A granted | +1,190,476 | $21 | 2,159,694 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-463547 | Quarter ended 2026-09-30 | 2026-11-16 | ||
| Form 4 0001193125-26-445438 | Rapport Therapeutics, Inc. | 2026-11-03 | ||
| 13F-HR 0001193125-26-340715 | Quarter ended 2026-06-30 | 2026-08-10 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-212009 | Quarter ended 2026-03-31 | 2026-05-07 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-051801 | Quarter ended 2025-12-31 | 2026-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-25-280201 | Quarter ended 2025-09-30 | 2025-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-007374 | Quarter ended 2025-06-30 | 2025-08-08 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-004484 | Quarter ended 2025-03-31 | 2025-05-09 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-002039 | Quarter ended 2024-12-31 | 2025-02-13 | acceptance time not in the bulk data set |